The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes
- PMID: 23342076
- PMCID: PMC3546962
- DOI: 10.1371/journal.pone.0054064
The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes
Abstract
Background: Several linkage analyses have mapped a susceptibility locus for diabetic nephropathy to chromosome 18q22-23, and polymorphisms within the carnosine dipeptidase 1 gene (CNDP1), located on 18q22.3, have been shown to be associated with diabetic nephropathy in European subjects with type 2 diabetes. However, the association of this locus with diabetic nephropathy has not been evaluated in the Japanese population. In this study, we examined the association of polymorphisms within the CNDP1/CNDP 2 locus with diabetic nephropathy in Japanese subjects with type 2 diabetes.
Methodology/principal findings: We genotyped a leucine repeat polymorphism (D18S880) that is within CNDP1 along with 29 single nucleotide polymorphisms (SNPs) in the CNDP1/CNDP2 locus for 2,740 Japanese subjects with type 2 diabetes (1,205 nephropathy cases with overt nephropathy or with end-stage renal disease [ESRD], and 1,535 controls with normoalbuminuria). The association of each polymorphism with diabetic nephropathy was analysed by performing logistic regression analysis. We did not observe any association between D18S880 and diabetic nephropathy in Japanese subjects with type 2 diabetes. None of the 29 SNPs within the CNDP1/CNDP2 locus were associated with diabetic nephropathy, but a subsequent sex-stratified analysis revealed that 1 SNP in CNDP1 was nominally associated with diabetic nephropathy in women (rs12604675-A; p = 0.005, odds ratio [OR] = 1.76, 95% confidence interval [CI], 1.19-2.61). Rs12604675 was associated with overt proteinuria (p = 0.002, OR = 2.18, 95% CI, 1.32-3.60), but not with ESRD in Japanese women with type 2 diabetes.
Conclusions/significance: Rs12604675-A in CNDP1 may confer susceptibility to overt proteinuria in Japanese women with type 2 diabetes.
Conflict of interest statement
Figures

Similar articles
-
Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.Diabetologia. 2011 Sep;54(9):2295-302. doi: 10.1007/s00125-011-2178-5. Epub 2011 May 15. Diabetologia. 2011. PMID: 21573905
-
Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.Diabetes. 2008 Sep;57(9):2547-51. doi: 10.2337/db07-1303. Diabetes. 2008. PMID: 18753673 Free PMC article.
-
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans.Nephrol Dial Transplant. 2007 Apr;22(4):1131-5. doi: 10.1093/ndt/gfl717. Epub 2007 Jan 5. Nephrol Dial Transplant. 2007. PMID: 17205963 Clinical Trial.
-
[Carnosine, carnosinase and kidney diseases].Postepy Hig Med Dosw (Online). 2012 Apr 20;66:215-21. doi: 10.5604/17322693.991600. Postepy Hig Med Dosw (Online). 2012. PMID: 22706107 Review. Polish.
-
Carnosine and Diabetic Nephropathy.Curr Med Chem. 2020;27(11):1801-1812. doi: 10.2174/0929867326666190326111851. Curr Med Chem. 2020. PMID: 30914013 Review.
Cited by
-
The (CTG)n repeat polymorphism in CNDP1 gene: New insights into an old molecule.Indian J Med Res. 2016 Jul;144(1):6-8. doi: 10.4103/0971-5916.193276. Indian J Med Res. 2016. PMID: 27834319 Free PMC article. No abstract available.
-
Serum Carnosinase 1 Is Not Associated with Insulin Resistance or Glucose Metabolism in a Type 1 Diabetes Cohort.Biomedicines. 2025 Feb 5;13(2):366. doi: 10.3390/biomedicines13020366. Biomedicines. 2025. PMID: 40002779 Free PMC article.
-
Genetic and Epigenetic Studies in Diabetic Kidney Disease.Front Genet. 2019 Jun 7;10:507. doi: 10.3389/fgene.2019.00507. eCollection 2019. Front Genet. 2019. PMID: 31231424 Free PMC article. Review.
-
Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical Applications.Curr Pharm Des. 2025;31(8):619-629. doi: 10.2174/0113816128333694240928161703. Curr Pharm Des. 2025. PMID: 39415582 Review.
-
Genotype Distribution of CNDP1 Polymorphisms in the Healthy Chinese Han Population: Association with HbA1c and Fasting Blood Glucose.J Diabetes Res. 2020 Jul 18;2020:3838505. doi: 10.1155/2020/3838505. eCollection 2020. J Diabetes Res. 2020. PMID: 32733966 Free PMC article.
References
-
- ERA-EDTA Registry committee (2012) ERA-EDTA Registry Annual Report 2010. Amsterdam: Academic Medical Center.
-
- Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, et al. (2012) Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial 16: 11–53. - PubMed
-
- Maeda S (2008) Genetics of diabetic nephropathy. Ther Adv Cardiovasc Dis 2: 363–371. - PubMed
-
- Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, et al. (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3–23. Kidney Int 62: 2176–2183. - PubMed
-
- Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, et al. (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1 . Diabetes 54: 2320–2327. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous